Optimal design and endpoint of clinical trials using immune checkpoint blocking agents.
作者信息
Keam Bhumsuk, Jung Hun, Nam Byung Ho
机构信息
a Department of Internal Medicine , Seoul National University Hospital , Seoul , Republic of Korea.
b Merck Sharp & Dohme , Seoul , Republic of Korea.
出版信息
Expert Rev Anticancer Ther. 2016 Dec;16(12):1217-1218. doi: 10.1080/14737140.2016.1248945. Epub 2016 Oct 28.
Abstract
摘要
Zotero 插件